Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe

Two biosimilars of Eli Lilly’s blockbuster osteoporosis treatment Forsteo – from Hungary’s Gedeon Richter and German partner Stada – have made their debut in Europe.